# Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

> **NCT00455585** · PHASE4 · COMPLETED · sponsor: **Makerere University** · enrollment: 18 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** nevirapine, stavudine, lamivudine

## Key facts

- **NCT ID:** NCT00455585
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-05
- **Final completion:** 2007-11
- **Target enrollment:** 18 (—)
- **Last updated:** 2008-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455585, "Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00455585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*